Top Cities for Tuberous Sclerosis Clinical Trials
Tuberous Sclerosis clinical trials are recruiting across 10 cities. Here are the cities with the most active studies:
About Tuberous Sclerosis
Tuberous sclerosis complex is a rare genetic disease that causes non-cancerous tumors to grow in many parts of the body including the brain, kidneys, heart, and skin. Symptoms vary widely depending on tumor location. Treatment includes mTOR inhibitors and management of specific symptoms.
Clinical trials are advancing new treatments for tuberous sclerosis. Currently, 1 studies are recruiting a combined 64 participants across the United States. Research is being conducted by 1 organizations including Darcy Krueger.
2026 Tuberous Sclerosis Research Landscape
As of March 2026, the tuberous sclerosis clinical trial landscape includes 1 actively recruiting studies across 10 cities in the United States. These studies are collectively seeking 64 participants, with an average enrollment target of 64 per study.
Research is being led by 1 organization, including Darcy Krueger.
Geographically, tuberous sclerosis trials are most concentrated in Birmingham, Alabama (1 trial); Los Angeles, California (1 trial); Palo Alto, California (1 trial); Aurora, Colorado (1 trial); Chicago, Illinois (1 trial) and 5 other cities.
Featured Tuberous Sclerosis Studies
Highlighted recruiting studies for tuberous sclerosis, selected by enrollment size and research scope.
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
This trial is a Phase II randomized, double-blind, placebo controlled multi-site study to evaluate the safety and efficacy of early sirolimus to prevent or delay seizure onset in TSC infants. This study is supported by research funding from the Office of Orphan Products Division (OOPD) of the US Food and Drug Administration (FDA).
Frequently Asked Questions About Tuberous Sclerosis Clinical Trials
Are there tuberous sclerosis clinical trials near me?
Yes, there are 1 tuberous sclerosis clinical trials currently recruiting across 10+ cities in the United States, including Birmingham, Alabama; Los Angeles, California; Palo Alto, California. Browse the studies above to find one at a location convenient for you.
How do I join a tuberous sclerosis clinical trial?
To join a tuberous sclerosis clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are tuberous sclerosis clinical trials free?
Yes, participation in tuberous sclerosis clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of tuberous sclerosis treatments are being studied?
Current tuberous sclerosis clinical trials are testing a range of approaches. These include new drugs, combination therapies, medical devices, and other interventions sponsored by 1 research organizations.
Is it safe to participate in tuberous sclerosis clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated March 1, 2026 from ClinicalTrials.gov
About This Data
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated March 1, 2026 · Data from ClinicalTrials.gov